TEMPLATE DESIGN © 2008 www.PosterPresentations.com ONCOLOGICAL REFERRAL PATTERNS OF GYNAECOLOGICAL CANCER PATIENTS OVER 2010 – 2011 THE NEED FOR GYNAECOLOGIC.

Slides:



Advertisements
Similar presentations
Yasir Rudha, MD; Amr Aref, MD; Paul Chuba, MD; Kevin O’Brien, MD
Advertisements

Audit of Impact of NICE guidelines for Ovarian Cancer Helen Losty Royal United Hospital Bath 17th November 2011.
Gynecologic Oncology Group Gynecologic Oncology Group Uterine Corpus Trials: GCIG David Scott Miller, M.D., F.A.C.O.G., F.A.C.S. Director and Dallas Foundation.
Endometrial Cancer May 2007 Dr Anna Winship Guy’s & St. Thomas’ NHS Trust Click Here For First Question Oncology Registrars’ Forum “Best of Five”
TEMPLATE DESIGN © Overview: Management Of Ovarian Cancer in Primary Care (1)Fabian Lee, Foundation Year 2. (2) Gbolahan.
Incorporating Cesium-131 Interstitial Implants into Daily Clinical Practice: How to Make Radiation appear exactly where you want. Jonathan Feddock, MD.
Cervical Cancer DR KHALID H. WALI SAIT (FRCSC) ASSOCIATE PROFESSOR OF GYNECOLOGICAL ONCOLOGY King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
Management of Vulval Cancer Services in South West England Jenny Weeks J Verne L Hirschowitz, V Udaysanker, AD Falconer on behalf SWCIS Gynaecology Tumour.
Epidemiology of Gynaecological Cancers. General Overview On global basis cervical cancer is the most common pelvic malignancy in developing countries.
SURGICAL APPROACH TO GYNAECOLOGICAL CANCERS
Endometrial Cancer Tseng Jen-Yu 02/05/2007 Tseng Jen-Yu 02/05/2007.
Malignant disease of the cervix
Gynaecological Cancers
Special Tutorial Programme Professor Deirdre J Murphy Trinity College.
A significant increase in the incidence of endometrial cancer. This increased incidence of endometrial cancer has been widely interpreted to be a result.
Abnormal Uterine Bleeding
A surgical approach to uterine cancer in a single institution August July 2014 M. McCarthy (Medical Student) & M. Hewitt Cork University Maternity.
District 1 ACOG Medical Student Teaching Module 2009
Carcinoma of the Endometrium1 CARCINOMA OF THE ENDOMETRIUM Wen Di, M.D. , Ph.D.
Female Genital Tract 1-Vulva 2-Vagina 3-Cervix 4-Uterine corpus
Post Menopausal Bleeding
CARCINOMA OF THE ENDOMETRIUM
OVARIAN CANCER Talking point: Genetics of ovarian cancer.
Evidence Based Decision Making In Gynecologic Cancer Paolo Zola Turin, ITALY Adriana Bermudez Buenos Aires, ARGENTINA.
Management of Gynaecological Cancers. Gynaecological Cancers in NSW 1180 new cases in % of all new cancer diagnoses Crude incidence rate 35.3 per.
Background The 2 week wait referral system was designed to expedite the referral of patients, suspected to have cancer, from Primary to Secondary care.
Endometrial Cancer ASSOCIATE PROFESSOR Iolanda Blidaru MD, PhD.
Malignant disease of the body of the uterus  The most common malignant diseas affecting the uterus is endometrial carcinoma, which arises from the lining.
 The term post menopause is applied to women who have not experienced a menstrual bleed for a minimum of 12 months, assuming that they do still have.
Cervical Cancer. Cervix Lower part of the uterus Lower part of the uterus Connects the body of the uterus to the vagina (birth canal) Connects the body.
Endometrial Carcinoma Fuat Demirkıran, MD Istanbul University, Cerrahpaşa School Of Medicine, OB&GYN Department, Gyn Oncology.
Fertility Sparing in Gynecological Cancers
Post-menopausal bleeding PV Dr Nasira Sabiha Dawood.
BY DR. KHANSA IQBAL SENIOR REGISTRAR GYNAE UNIT-II.
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 1 Abnormal Bleeding CAPT Mike Hughey, MC, USNR.
TEMPLATE DESIGN © Primary Peritoneal Carcinoma found at caeserean section, value of routine abdominal examination at caeserean.
PATTERN OF GYNAECOLOGICAL MALIGNANCIES IN DELTA STATE UNIVERSITY TEACHING HOSPITAL,OGHARA:A 2 YEAR REVIEW. MOFON C EBEIGBE P.E ABEDI H.O DELSUTH.
Carcinoma Corpus Uteri
Endometrial Carcinoma
Are there benefits from chemotherapy to early endometrial cancer
Definitive chemo-radiotherapy for esophageal cancer; failure pattern and salvage treatments Ryuta Koike, Y. Nishimura, K. Nakamatsu, S. Kanamori, M. Okubo,
Histopathological evaluation of lymphatic nodules in cancer of the uterine cervix Coordinators: First Author: Asist. Univ. Dr. Chira Liliana Stud. Bogdan.
TEMPLATE DESIGN © EPIDEMIOLOGY AND PATHOLOGY OF GYNAECOLOGICAL CANCER AT BENAZIR BHUTTO HOSPITAL, RAWALPINDI, PAKISTAN.
Michael Birrer Ian McNeish New Developments in Biology and Targets of Epithelial Ovarian Cancer.
TEMPLATE DESIGN © Endometrial large cell neuroendocrine carcinoma : a case report Reina Sato, Aiko Kawano, Hiroyuki Shigeta.
Urinary Tract System Bladder Cancer.
Mahatma Gandhi Cancer Hospital and Research Institute Dr P. S. Bhattacharyya, MD Radiation Oncologist. Elekta Synergy CT Simulator Flexitron HDR.
‘Let’s get it right - Referral for suspected Cancer’
Gynecological Malignancies. Gynecologic malignancies account for 15% of all cancers in women. Gynecologic malignancies account for 15% of all cancers.
TEMPLATE DESIGN © Uterine sarcomas in RIPAS Hospital, Brunei; a 10 year retrospective study. Dr Alice Kurien, Dr Saw Ohnmar,
Malignant & Pre-malignant Diseases of the Endometrium Jose B Moran MD Assistant Professor III Section of Gynecologic Oncology Department of Obstetrics.
Invasive cervical cancer. Background Most common cancer of women in Africa, most common gynaecologic cancer, most common cancer of black and coloured.
ENDOMETRIAL CARCINOMA UPDATES Dr Marco Matos Gold Coast Cancer Care, Gold Coast University Hospital and Pacific Private Oncology Group.
Consultant Obstetrician & Gynaecologist
HE-4 TRIAL Prospective phase II trial on the prognostic and predictive value of HE-4 regression during neoadjuvant chemotherapy for advanced ovarian, Fallopian.
Gynecologic Oncology New or Old subspecialty Samir Fouad Khalaf Professor OBGYN Al-Azhar University President
NEOADJUVANT CHEMOTHERAPY FOR ADVANCED ENDOMETRIAL CANCER
Liver surgery for metachronous hepatic metastases with uterine body and uterine cervix origin – a single center experience Nicolae Bacalbasa (1), Irina.
Uterine serous carcinoma is more aggressive than high-grade serous ovarian carcinoma: a retrospective study H. Nagano1, Y. Tachibana1, M. Kawakami1, M.
Post Menopausal Bleeding
(cervical cancer only)
Figure #1 Overall survival Figure #2 Disease free survival
Concurrent chemotherapy and hyperthermia in patients with recurrent cervical cancer after chemoradiation: outcome and survival S.T. Heijkoop1,2; H.C. van.
Marcelo Calil Instituto Brasileiro de Controle do Câncer
Emergency Presentations in Gynaecological Oncology
Prof.S.M.Haider Faisal Hameed Wahab Kadri
Ovarian Cancer-Route to Diagnosis
Breast Multidisciplinary Team Meetings
Airedale NHS Foundation Trust
Suspected Gynaecological Cancer Recognition & Referral
Presentation transcript:

TEMPLATE DESIGN © ONCOLOGICAL REFERRAL PATTERNS OF GYNAECOLOGICAL CANCER PATIENTS OVER 2010 – 2011 THE NEED FOR GYNAECOLOGIC ONCOLOGY SUBSPECIALITY SERVICES Asma Tanvir Usmani, Samra Ayub, Ayesha Basharat Benazir Bhutto Hospital, Rawalpindi, Pakistan INTRODUCTIONRESULTS CONCLUSIONS For the most part, gynaecological cancers can be treated for cure. As with the majority of solid tumor cancers, if gynaecologic cancers are discovered at an early stage, surgery can be curative, and other treatments, such as radiotherapy or chemotherapy may be given post- operatively to consolidate treatment (i.e., adjuvant treatment). The number of patients referred from the study hospital over a 1.5-year period is reported. The increase in the utilization of the oncologist by the general gynaecologist over the study period is detailed. The impact of gynaecologic oncology subspecialty services on referral patterns of uterine cancer in a tertiary hospital has not been explored in the literature. Gynaecological malignancy referrals contribute to a great burden of out-of-hospital referrals. The availability of gynaecologic oncology subspeciality services can result in: a rapid decline in these referrals an increase in the number of patients treated a gradual transfer of responsibility for primary management from general gynaecologist to gynaecologic oncologists. METHODS The study was carried out at the Department of Obstetrics & Gynaecology at Benazir Bhutto Hospital, Rawalpindi, Pakistan. We reviewed the medical records of patients who were referred to oncology (NORI) for gynaecological cancers, from Feb 2010 to Aug Based on these records, we assessed the clinical presentation of these patients and the reasons for referral. OPTIONAL LOGO HERE Duration of study: February 2010 to August 2011 Setting : Department Of Obstetrics & Gynaecology, Benazir Bhutto Hospital, Rawalpindi Sample size: 32 patients OBJECTIVES Clinical presentation and the reason for referral of the patients diagnosed with gynaecological malignancies. 32 patients diagnosed with gynaecological malignancies Reasons for referral Clinical features We referred 32 patients with gynaecological malignancy to NORI. The age of the patients ranged from 13 to 80 years with a mean age of  16 years. The most common malignancy was ovarian carcinoma in 14 (43.75%) patients with a mean age of 40.5  13.5 years. The youngest patient was 13 years of age with mixed malignant germ cell tumor. The next most frequent malignancy was cervical carcinoma in 10 (31.3%) patients with suamous cell ca in 9 and adenocarcinoma in 1 patient; with a mean age of 57  13.7 years. Less common tumors included endometrial carcinoma in 2 (6.25%) with mean age of 45.2  16.6 years, vulval suamous cell carcinoma in 4 (12.5%) with mean age of 45  23.5 years and vaginal carcinoma in 1 (3.1%) with mean age of 52 years. 4 (12.5%) patients presented with recurrence after treatment of primary malignancy. All patients had their primary surgery done before referral if it was indicated. The reason for referral was for opinion about chemo-radiotherapy. Site of malignancyNMean (Years) Ovarian carcinoma ± 13.5 Cervical carcinoma1057 ± 13.7 Endometrial carcinoma245.2 ± 16.6 Vulval carcinoma445 ± 23.5 Vaginal carcinoma152 Histopathology of gynaecological cancers Frequency Ovarian carcinoma14 (43.75%) Papillary serous adenocarcinoma 3 Germ cell tumors 1 Endometroid adenocarcinoma 2 Immature teratoma 1 Cervical carcinoma10 (31.3%) Squamous cell carcinoma 08 Adenocarcinoma 2 Endometrial carcinoma2 (6.25%) Leiomyosarcoma 1 Adenosquamous carcinoma 1 Vulval squamous cell carcinoma4 (12.5%) Vaginal small cell carcinoma1 (3.1%) CA Cervix CA Ovary CA Endometrium CA Vulva CA Vagina Stage of malignancy I44 II11 III413 IV18211 Treatment at Benazir Bhutto Hospital EUA + Biopsy 9241 Radiological16 Primary staging surgery 7 Secondary surgery 2 Reason for referral Neoadjuvant11 Chemotherapy21221 Radiotherapy10131 Recurrance211